PCV10 vaccine significantly reduced childhood pneumonia in Kilifi, Kenya

Research Brief, March 2019





The introduction of 10-valent Pneumococcal Conjugate Vaccine (PCV10) led to a substantial reduction in the number of children hospitalized with pneumonia in Kilifi, Kenya. This brief presents results from the Pneumococcal Conjugate Vaccine Impact Study (PCVIS) on incidence of clinically-diagnosed and radiologically confirmed pneumonia and highlights areas for further research.